Compared with the control (Figure 6B), PG and anti–PD-L1 suppressed tumor growth by 57% and 36%, respectively, whereas the combination of PG and anti–PD-L1 group (CP) reduced tumor growth by 52% at day 18 (Figure 6E). Here, CD274 is linked to neoplasm.